Current and historical daily PE Ratio for Roche Holding AG (
) from 2014 to May 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Roche Holding AG stock (LTS:0QOK) PE ratio as of May 19 2024 is 16.57.
More Details
Roche Holding AG (LTS:0QOK) PE Ratio (TTM) Chart
Roche Holding AG (LTS:0QOK) PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Total 1257
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Roche Holding AG PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-20 | 16.5 | 2024-03-13 | 17.0 |
| 2024-05-17 | 16.5 | 2024-03-12 | 17.1 |
| 2024-05-16 | 16.5 | 2024-03-11 | 16.8 |
| 2024-05-15 | 15.8 | 2024-03-08 | 16.6 |
| 2024-05-14 | 15.7 | 2024-03-07 | 16.5 |
| 2024-05-13 | 15.9 | 2024-03-06 | 16.4 |
| 2024-05-10 | 15.7 | 2024-03-05 | 16.6 |
| 2024-05-09 | 15.5 | 2024-03-04 | 16.3 |
| 2024-05-08 | 15.5 | 2024-03-01 | 16.2 |
| 2024-05-07 | 15.5 | 2024-02-29 | 16.2 |
| 2024-05-03 | 15.1 | 2024-02-28 | 16.2 |
| 2024-05-02 | 15.0 | 2024-02-27 | 16.3 |
| 2024-05-01 | 15.4 | 2024-02-26 | 16.3 |
| 2024-04-30 | 15.4 | 2024-02-23 | 16.1 |
| 2024-04-29 | 15.5 | 2024-02-22 | 15.9 |
| 2024-04-26 | 15.4 | 2024-02-21 | 16.1 |
| 2024-04-25 | 15.3 | 2024-02-20 | 16.2 |
| 2024-04-24 | 15.6 | 2024-02-19 | 16.0 |
| 2024-04-23 | 15.9 | 2024-02-16 | 15.8 |
| 2024-04-22 | 15.9 | 2024-02-15 | 15.8 |
| 2024-04-19 | 15.3 | 2024-02-14 | 15.9 |
| 2024-04-18 | 15.3 | 2024-02-13 | 15.9 |
| 2024-04-17 | 15.4 | 2024-02-12 | 15.7 |
| 2024-04-16 | 15.4 | 2024-02-09 | 15.7 |
| 2024-04-15 | 15.8 | 2024-02-08 | 15.9 |
| 2024-04-12 | 15.8 | 2024-02-07 | 16.1 |
| 2024-04-11 | 15.9 | 2024-02-06 | 15.9 |
| 2024-04-10 | 15.6 | 2024-02-05 | 16.1 |
| 2024-04-09 | 15.5 | 2024-02-02 | 16.5 |
| 2024-04-08 | 15.3 | 2024-02-01 | 16.5 |
| 2024-04-05 | 15.6 | 2024-01-31 | 17.3 |
| 2024-04-04 | 15.8 | 2024-01-30 | 17.2 |
| 2024-04-03 | 15.9 | 2024-01-29 | 17.2 |
| 2024-04-02 | 16.1 | 2024-01-26 | 17.3 |
| 2024-03-28 | 15.9 | 2024-01-25 | 16.8 |
| 2024-03-27 | 15.9 | 2024-01-24 | 17.0 |
| 2024-03-26 | 15.8 | 2024-01-23 | 17.1 |
| 2024-03-25 | 15.8 | 2024-01-22 | 17.2 |
| 2024-03-22 | 15.9 | 2024-01-19 | 17.3 |
| 2024-03-21 | 15.8 | 2024-01-18 | 17.3 |
| 2024-03-20 | 16.1 | 2024-01-17 | 17.3 |
| 2024-03-19 | 16.0 | 2024-01-16 | 17.4 |
| 2024-03-18 | 16.1 | 2024-01-15 | 17.7 |
| 2024-03-15 | 16.3 | 2024-01-12 | 17.6 |
| 2024-03-14 | 16.3 | 2024-01-11 | 17.7 |
Roche Holding AG (LTS:0QOK) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Roche Holding AG
NAICS : 325412
SIC : 2834
ISIN : CH0012032048
Share Class Description:
LTS:0QOK: Ordinary SharesDescription
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers